Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review.
Autoimmune chronic spontaneous urticaria
Basophil activation test
Basophil histamine release assay
Biomarker
Mast cell
Treatment
Type IIb aiCSU
Journal
The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
06
02
2023
revised:
21
04
2023
accepted:
19
05
2023
medline:
11
8
2023
pubmed:
8
6
2023
entrez:
7
6
2023
Statut:
ppublish
Résumé
Chronic spontaneous urticaria (CSU) is believed to be Autoimmune (aiCSU) (type IIb CSU) in at least 8% of patients, associated with mast cell-activating IgG autoantibodies. Basophil tests such as the basophil activation test (BAT) and basophil histamine release assay (BHRA) are considered the best single tests for an aiCSU diagnosis. To date, the strength of associations among a positive BAT and/or BHRA (BAT/BHRA To evaluate the strength of current evidence on basophil tests as parameters for CSU characteristics. We performed a systematic literature search and review to assess the relationship between BAT/BHRA In CSU patients, BAT/BHRA Our results suggest that aiCSU defined by BAT/BHRA
Sections du résumé
BACKGROUND
Chronic spontaneous urticaria (CSU) is believed to be Autoimmune (aiCSU) (type IIb CSU) in at least 8% of patients, associated with mast cell-activating IgG autoantibodies. Basophil tests such as the basophil activation test (BAT) and basophil histamine release assay (BHRA) are considered the best single tests for an aiCSU diagnosis. To date, the strength of associations among a positive BAT and/or BHRA (BAT/BHRA
OBJECTIVE
To evaluate the strength of current evidence on basophil tests as parameters for CSU characteristics.
METHODS
We performed a systematic literature search and review to assess the relationship between BAT/BHRA
RESULTS
In CSU patients, BAT/BHRA
CONCLUSIONS
Our results suggest that aiCSU defined by BAT/BHRA
Identifiants
pubmed: 37286132
pii: S2213-2198(23)00603-7
doi: 10.1016/j.jaip.2023.05.039
pii:
doi:
Substances chimiques
Immunoglobulin E
37341-29-0
Types de publication
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2411-2416Informations de copyright
Copyright © 2023 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.